Nazrul Islam, Sharmin Shabnam, Nusrat Khan, Clare Gillies, Francesco Zaccardi, Amitava Banerjee, Vahé Nafilyan, Kamlesh Khunti, Hajira Dambha-Miller, Linda Gough
The availability of population scale data as a result of the covid-19 pandemic has provided actionable insights for policy makers but needs to expand beyond pandemic planning, argue Batty and colleagues.
Winter poses a substantial challenge to healthcare systems as a consequence of colder weather exacerbating pre-existing health issues, increased circulation of seasonal viruses, social factors (increased isolation and loneliness), and difficulties at the systems level (higher bed occupancy and greater staff absences).1 2 The growing prevalence of multimorbidity—defined as the presence of multiple long term conditions in an individual3—further exacerbates these pressures.
Although the impact of multimorbidity on hospital admission and all cause mortality is well documented,4 the effect of specific combinations of long term conditions in the winter remains unclear. To investigate this, Islam and colleagues (doi:10.1136/bmjmed-2024-001016) conducted a population based, retrospective cohort study with coverage of 48.2 million adults in England, using routinely collected, linked primary and secondary care data.5 The authors ascertained 59 long term conditions and reduced these to 19 groups based on clinician, policymaker, and patient input. The overall prevalence of multimorbidity was 31.2%, in line with previous estimates in this population.6 Individuals with cancer, kidney disease, cardiovascular disease, and type 2 diabetes mellitus were observed to be 11-fold (95% confidence interval (CI) 9.4 to 12.7) more likely to be admitted to hospital during winter (December 2021 to March 2022) than those without long term conditions. Those individuals with kidney disease, cardiovascular disease, dementia, and osteoarthritis were 24.3-fold (95% CI 19.1 to 30.4) more likely to die during winter than those without long term conditions.
Multimorbidity could increase hospital admission and mortality during winter by increasing vulnerability to the development of critical illness in response to seasonal viruses as a result of impaired control of viral replication, dysregulated host immune responses, and diminished physiological reserves.7 Coexisting frailty and disability could increase the risk of unexpected social care needs that cannot be met in the community during winter.8 Specific long term conditions might also mediate excess adverse outcomes (eg, resting blood pressure peaks in winter, increasing the risk of cardiovascular events).9
This study by Islam and colleagues showed that individuals with specific combinations of long term conditions were at greater risk of hospital admission and mortality during winter after accounting for age, sex, ethnic group, and socioeconomic deprivation, which has several potential key implications for health policy. Firstly, the large number of combinations of long term conditions observed in this study reinforces the need for joined-up, patient centred models of care; many long term conditions continue to be managed by hospital based specialists, with the overall care of the patient coordinated in primary care. New models of integrated community, hospital, and social care are likely to offer better support to those people living with multimorbidity, but will require paradigm shifts in commissioning and organisational culture. Secondly, the most adverse combinations included multiple long term conditions with common risk factors, including smoking, obesity, and a sedentary lifestyle, suggesting that prioritising the management of these risk factors earlier in an individual's life course might have synergistic benefits in preventing multimorbidity and consequent adverse clinical outcomes.
The future development of this work might help identify those people at greatest risk of unplanned admission and enable _targeted, evidence based interventions to prevent hospital admission,10 including enhanced community based care11 and vaccination against winter viruses.12 However, Islam and colleagues recognise that this descriptive, observational study was able to estimate the population level burden of hospital admission and mortality, rather than derive a clinical prediction model at the individual level (a pre-requisite for clinical implementation). The authors also assert that further work is required to understand whether the associations identified between combinations of long term conditions, hospital admission, and mortality have any causal interpretation, and that their selection of long term conditions is key to their findings (ie, alternative selection of conditions could lead to different findings). Therefore, further work is still required for data such as these to directly inform clinical practice and to allow robust translation of these findings into risk stratification for individuals.
This study had several methodological strengths. Firstly, the use of individual level primary and secondary care data, linked at whole population scale, enabled the robust and representative inference required to inform healthcare policy. Access to these high quality data were made possible by the CVD-COVID-UK/COVID-IMPACT Consortium and the combined work of Health Data Research UK and the British Heart Foundation Data Science Centre, with secure access provided through trusted research environments.13 These data became available as a result of changes to legislation made during the covid-19 pandemic to enable timely, data driven, policy responses, but data linkage at this scale remains restricted to research focused on pandemic planning.14 Secondly, the authors evaluated specific combinations of long term conditions rather than limiting their analysis to the binary definition of multimorbidity. This approach has enabled specific, actionable insights, including finding that certain two-condition dyads (eg, cardiovascular disease and dementia) were associated with a greater risk of hospital admission and death than many combinations of three, four, and five diseases. Future research on multiple long term conditions should continue to evaluate which conditions individuals have,15 in addition to incorporating metadata regarding order of accrual,16 duration, and severity.
This study also highlights the considerable methodological complexity of studying the synergistic impact of many long term conditions. There are 5.8×1017 hypothetical combinations of 59 conditions, of which over 500 000 were observed by the authors. Enumerating and meaningfully interpreting combination-outcome associations at this scale remains intractable, even in a whole population study. Accordingly, a practical decision was made to simplify the initial list of conditions to the 19 most important conditions, and to report only the top associations by effect size. In future, sophisticated methods including clustering,17 regularisation18 and dimensionality reduction19 may reduce complexity while preserving key interactions between a larger number of long term conditions. Finally, the authors identified combinations of long term conditions most associated with adverse outcomes during winter, but their study design was not able to quantify the excess risk beyond that observed in non-winter months, or comment on the preventability of hospital admissions and deaths.
In conclusion, this study demonstrated that multimorbidity patterns are a major determinant of hospital admission and mortality during winter. In the broader context of winter pressures and increasing multimorbidity, it underscores the need for methods that can identify individuals at high risk of preventable hospital admission and mortality, and strategies to mitigate the risk observed for those people with the most adverse combinations of long term conditions. Lastly, although other examples of high impact analyses of population scale data are emerging,20 21 it is of critical importance to make these data available beyond the context of pandemic planning, in order to answer some of the most important questions in healthcare, health policy, and society.
X: @JonnyBatty, @Marlous3011
Contributors: JAB drafted the initial text, LS and MH reviewed it and provided feedback and suggested changes. All authors contributed to editing and final approval of the manuscript.
Funding: JAB received funding from a 4ward North Clinical PhD Fellowship (Wellcome Trust; 227498/Z/23/Z). MH received funding from a Sir Henry Wellcome Fellowship (Wellcome Trust; 206470/Z/17/Z).
Competing interests: Competing interests: We have read and understood the BMJ policy on declaration of interests and declare the following interests: none.
Provenance and peer review: Commissioned; not externally peer reviewed.
Callaly E, Mikulich O, Silke B, et al. Increased winter mortality: the effect of season, temperature and deprivation in the acutely ill medical patient. Eur J Intern Med 2013; 24:546–51. doi:10.1016/j.ejim.2013.02.004•Google Scholar Elliot AJ, Cross KW, Fleming DM, et al. Acute respiratory infections and winter pressures on hospital admissions in England and Wales 1990-2005. J Public Health (Oxf) 2008; 30:91–8. doi:10.1093/pubmed/fdn003•Google Scholar Johnston MC, Crilly M, Black C, et al. Defining and measuring multimorbidity: a systematic review of systematic reviews. Eur J Public Health 2019; 29:182–9. doi:10.1093/eurpub/cky098•Google Scholar Rodrigues LP, de Oliveira Rezende AT, Delpino FM, et al. Association between multimorbidity and hospitalization in older adults: systematic review and meta-analysis. Age Ageing 2022; 51. doi:10.1093/ageing/afac155•Google Scholar Islam N, Shabnam S, Khan N, et al. Combinations of multiple long term conditions and risk of hospital admission or death during winter 2021-22 in England: population based cohort study. BMJ MED 2024; doi:10.1136/bmjmed-2024-001016•Google Scholar Cassell A, Edwards D, Harshfield A, et al. The epidemiology of multimorbidity in primary care: a retrospective cohort study. Br J Gen Pract 2018; 68:e245–51. doi:10.3399/bjgp18X695465•Google Scholar Russell CD, Lone NI, Baillie JK, et al. Comorbidities, multimorbidity and COVID-19. Nat Med 2023; 29:334–43. doi:10.1038/s41591-022-02156-9•Google Scholar Simpson G, Stokes J, Farmer A, et al. Social care need in multimorbidity. J R Soc Med 2023; 116:124–7. doi:10.1177/01410768231168382•Google Scholar Fares A. Winter cardiovascular diseases phenomenon. N Am J Med Sci 2013; 5:266–79. doi:10.4103/1947-2714.110430•Google Scholar Edgar K, Iliffe S, Doll HA, et al. Admission avoidance hospital at home. Cochrane Database Syst Rev 2024; 3. doi:10.1002/14651858.CD007491.pub3•Google Scholar Johnston J, Longman J, Ewald D, et al. Study of potentially preventable hospitalisations (PPH) for chronic conditions: what proportion are preventable and what factors are associated with preventable PPH? BMJ Open 2020; 10. doi:10.1136/bmjopen-2020-038415•Google Scholar Antonelli Incalzi R, Consoli A, Lopalco P, et al. Influenza vaccination for elderly, vulnerable and high-risk subjects: a narrative review and expert opinion. Intern Emerg Med 2024; 19:619–40. doi:10.1007/s11739-023-03456-9•Google Scholar Hubbard T, Reilly G, Varma S, et al. UK health data research alliance: trusted research environments (tre) green paper (2.0.0). 2020; Available: hereGoogle ScholarCavallaro F, Lugg-Widger F, Cannings-John R, et al. Open letter: reducing barriers to data access for research in the public interest—lessons from covid-19. BMJ Opinion 2020; Available: hereGoogle ScholarHall M, Dondo TB, Yan AT, et al. Multimorbidity and survival for patients with acute myocardial infarction in England and Wales: Latent class analysis of a nationwide population-based cohort. PLoS Med 2018; 15. doi:10.1371/journal.pmed.1002501•Google Scholar Hayward CJ, Batty JA, Westhead DR, et al. Disease trajectories following myocardial infarction: insights from process mining of 145 million hospitalisation episodes. EBioMedicine 2023; 96. doi:10.1016/j.ebiom.2023.104792•Google Scholar Loftus TJ, Shickel B, Balch JA, et al. Phenotype clustering in health care: A narrative review for clinicians. Front Artif Intell 2022; 5. doi:10.3389/frai.2022.842306•Google Scholar Friedrich S, Groll A, Ickstadt K, et al. Regularization approaches in clinical biostatistics: A review of methods and their applications. Stat Methods Med Res 2023; 32:425–40. doi:10.1177/09622802221133557•Google Scholar Nguyen LH, Holmes S. Ten quick tips for effective dimensionality reduction. PLoS Comput Biol 2019; 15. doi:10.1371/journal.pcbi.1006907•Google Scholar Thygesen JH, Tomlinson C, Hollings S, et al. COVID-19 trajectories among 57 million adults in England: a cohort study using electronic health records. Lancet Digit Health 2022; 4:e542–57. doi:10.1016/S2589-7500(22)00091-7•Google Scholar Hall M, Smith L, Wu J, et al. Health outcomes after myocardial infarction: A population study of 56 million people in England. PLoS Med 2024; 21. doi:10.1371/journal.pmed.1004343•Google Scholar